Celexa birth defects include persistent pulmonary hypertension (PPHN), septal heart defects, as well as other malformations. Mothers who took this antidepressant during pregnancy and gave birth to a child with birth defects, should contact a Celexa lawyer. We are currently working with attorneys who have experience in this area and can file a Celexa lawsuit on your behalf. Also, there is no fee until you receive a settlement or award. Contact us for a free consultation online or give us a call toll free at 1-800-992-6878.

Pregnant woman holding her stomach and Celexa pills

Have You Suffered Any Serious Side Effects Due to Celexa?
Call Us Today! at 1-800-992-6878

Celexa (citalopram) belongs to the selective serotonin reuptake inhibitor (SSRI) class of antidepressants. It is used to treat major depressive disorder in adults. In July 1998, the FDA approved this antidepressant for sale on the market by its manufacturer, Forest Laboratories. This drug has earned Forest Laboratories billions of dollars since its introduction to the market. According to the Forest Laboratories’ 2012 annual report, Celexa was the company’s first blockbuster drug at $1.5 billion (i). However, the company is now facing challenges with the drug because its patent expired in July 2003 and a growing number of lawsuits allege the medication has caused birth defects, suicidal behavior, and violent acts.

Celexa Side Effects

woman talking with her doctor about feeling the Celexa side effects of joint pain and nausea

Common but less serious side effects of Celexa include drowsiness, muscle and joint pain, nausea, diarrhea, and sexual complications (ii). Celexa, like other SSRI antidepressants, has also been linked to serious adverse events like birth defects, heart arrhythmia, serotonin syndrome, and suicidal or violent behavior. Serious Celexa side effects may entitle you to monetary compensation to cover your losses.

Celexa Birth Defects

nurse listening to baby's heart to check for celexa side effects

Celexa and other SSRI drugs have been linked to heart and lung birth defects. In fact, in July 2006, the FDA announced a Public Health Advisory pertaining to this drug and detailing an increased risk of persistent pulmonary hypertension in newborns (PPHN). The study the FDA relied on found that “PPHN was six times more common in babies whose mothers took an SSRI antidepressant after the 20th week of the pregnancy.” PPHN is a condition that makes breathing difficult for newborns and in severe cases can lead to more life-threatening outcomes like brain damage, or even death (iii).

Mothers who have used SSRIs like Celexa during pregnancy and then gave birth to a child suffering from any of the following birth defects should contact a Celexa lawyer:

  • Abdominal birth defects
  • Blindness
  • Cleft lip or palate
  • Clubfoot
  • Down’s syndrome
  • Hernia
  • Hypoplastic Left/Right Heart Syndrome
  • Persistent Pulmonary Hypertension (PPHN)
  • Septal heart defects (atrial or ventricular)
  • Spina bifida
  • Or any other birth defects

Serotonin Syndrome and Heart Arrhythmia

In recent years, the FDA has warned about two dangerous conditions related to Celexa. Serotonin syndrome is a risk posed by all SSRIs, and in some cases, it may be life-threatening. This condition occurs when serotonin levels are too high due to prescription drug use. Symptoms of this condition include elevated heart rate, nausea, and hallucinations (iv). Most recently, the FDA has warned that doses of this SSRI over 40 mg may change the electrical activity in the heart. This change can result in QT prolongation, which is an irregular heartbeat. Such heart arrhythmias have been associated with a condition called torsades de pointes and even sudden cardiac death (v).

Celexa Suicide Risks

A celexa user that has developed suicidal thoughts

Since the 1990s, manufacturing and marketing of antidepressants has boomed and antidepressant use has grown. It is now estimated that 1 in 10 Americans use some form of antidepressant (vi). The increase in antidepressant use has provided greater insight into the use of these drugs and their accompanying risk of suicidal or violent behavior among young people. In October 2004, the FDA alerted the public to this risk by requiring all antidepressant manufacturers to include a warning that antidepressant use could increase the risk of suicidal behavior when used by children and teenagers. In May 2007, this warning was expanded to include young adults up to the age of 24 (vii).

Forest Laboratories and Celexa Lawsuits

Celexa Lawsuits over birth defects and off-label useForest Laboratories has faced a number of legal challenges due to its marketing of this drug and the adverse events suffered by patients. In September 2010, the company reached a $313 million dollar settlement with the U.S. Department of Justice. The settlement was paid because Forest Laboratories had been illegally marketing Celexa for off-label uses in children (viii). Recently, in the company’s 2012 annual report, it stated that it is defending 93 product liability lawsuits related to Celexa and Lexapro. Of these lawsuits, there are 14 Celexa suicide lawsuits and 79 Celaxa birth defects lawsuits. Many of the birth defect lawsuits allege that Celexa and Lexapro have caused PPHN (ix).

Please Talk To Your Doctor Before Discontinuing Celexa or Any Prescription Medication

Do You Need Legal Advice Concerning Your Potential Celexa Lawsuit?

Celexa Lawyer meeting with parents of child with birth defects looking for a Celexa LawsuitIf you or a loved has suffered birth defects, suicidal behavior, or other serious injuries due to taking Celexa, you may have a valid lawsuit. The qualified Celexa lawyers we work with would be more than happy to discuss your legal options with you, and they charge no fees until you receive a settlement or award.

Call our 24-hour phone line at 1-800-992-6878 or fill out a contact form, in order to receive a free legal consultation and begin pursuing your legal rights.


  • (i) Forest Laboratories 2012 Annual Report.
  • (ii) WebMD Celexa Side Effects.
  • (iii) FDA Public Health Advisory, July 2006.
  • (iv) FDA Public Health Advisory, July 2006.
  • (v) FDA Safety Communication, March 2012.
  • (vi) Time Magazine, January 2010.
  • (vii) FDA Drug Safety Information, May 2007.
  • (viii) The New York Times, September 2010.
  • (ix) Forest Laboratories 2012 Annual Report.